U.S. hospitals are increasingly integrating pharmacists into clinical care, but many are struggling to fill roles and maintain staff, according to the 2024 American Society of Health-System Pharmacists National Survey of Pharmacy Practice in Hospital Settings.  More than 75% of…

The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis following vaccination.  The updates reflect new data, including estimated unadjusted incidence rates…

Hospital pharmacists are increasingly involved in direct patient care roles, and in 2024, more than 75% of U.S. hospitals assign pharmacists to provide care for most inpatients, according to a report published June 25.  The American Society of Health-System Pharmacists…

CMS Administrator Mehmet Oz, MD, is calling on the nation’s largest pharmacy benefit managers to voluntarily abandon the current drug rebate model, or risk its elimination by the government, Bloomberg reported June 24.  “There’s a possibility that we have a…

Although the number of adverse health events has been climbing in Minnesota since 2015, hospitals decreased medication errors by 44% in the last year, according to the state’s health department.  In 2024, Minnesota hospitals and ambulatory surgery centers reported 624…

From streamlining prescription refills through mobile apps to using SMS alerts for real-time medication updates, health systems are reshaping the digital pharmacy experience with patients at the center.  Below are responses from three pharmacy leaders who were asked: How has…

In early 2020, as health systems across the U.S. were dealing with the COVID-19 pandemic, Danville, Pa.-based Geisinger’s leadership team was also rethinking the structure of its ambulatory pharmacy operations and distribution channels.  The result was the formation of Geisinger…

Jacqueline Corrigan-Curay, MD, acting director of the FDA’s Center for Drug Evaluation and Research, will step down in July after more than eight years at the agency, Bloomberg Law reported June 23.  In an internal email obtained by the publication,…

The FDA has granted accelerated approval to datopotamab deruxtecan (Datroway) for adults with locally advanced or metastatic non-small cell lung cancer that carries an EGFR mutation and has progressed. Datopotamab deruxtecan, the first TROP2-directed therapy approved for lung cancer in…

A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin altogether.  The research, published June 20 in The New…